Skip to main content
Contact Us
Subscribe
E-Edition
45°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caredx Inc
(NQ:
CDNA
)
24.54
+0.47 (+1.95%)
Streaming Delayed Price
Updated: 10:49 AM EST, Dec 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Caredx Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
Today 7:00 EST
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in Upcoming Investor Conferences
November 12, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
November 04, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
October 23, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
October 21, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Preliminary Financial Results for Third Quarter 2024
October 15, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints Jing Huang Chief Data and AI Officer
October 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Host Investor Day on October 15, 2024
October 08, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
October 08, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
September 12, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
August 16, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
July 31, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Second Quarter 2024 Financial Results
July 16, 2024
From
CareDx, Inc.
Via
Business Wire
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
June 03, 2024
From
CareDx, Inc.
Via
Business Wire
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
May 30, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
May 29, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in Upcoming Investor Conferences
May 29, 2024
From
CareDx, Inc.
Via
Business Wire
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
May 16, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports First Quarter 2024 Results
May 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Report First Quarter 2024 Financial Results
April 29, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
April 19, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
April 16, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
April 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints Bryan Riggsbee to Its Board of Directors
March 11, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
February 27, 2024
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.